-
Je něco špatně v tomto záznamu ?
Czechia: Health System Review
L. Bryndová, L. Šlegerová, J. Votápková, P. Hrobon, N. Shuftan, A. Spranger
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články
PubMed
36951272
Knihovny.cz E-zdroje
- MeSH
- COVID-19 * epidemiologie MeSH
- kvalita zdravotní péče MeSH
- lidé MeSH
- pandemie MeSH
- reforma zdravotní péče MeSH
- výdaje na zdravotnictví MeSH
- zdravotní pojištění MeSH
- zdravotní politika * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
This analysis of the Czech health system reviews developments in governance, organization, financing and delivery of care, health reforms and health system performance. Czechs have enjoyed a statutory health insurance system with a high level of financial protection, a broad benefits package and universal membership for over 30 years. The central level of the state, mostly represented through the Ministry of Health and its subordinated bodies, takes on the various roles of legislator, steward and even owner of various providers of care, while also making insurance contributions for the sizeable part of the population classified as economically inactive. Health insurance funds are responsible for contracting sufficient care provision for their members. The Czech health system has traditionally derived a majority of its financing from public sources, which stood at 81.5% of current health expenditure in 2019, as the latest available year of reference, with the rest coming from private sources. While health spending in Czechia is below the European Union (EU) average, the densities of acute care beds and primary care physicians are above respective EU averages. Ageing and a lack of qualified staff (for example, nurses in hospitals) are already putting pressure on the Czech health workforce, a bottleneck further exposed by the COVID-19 pandemic. Additionally, Czechia has embarked on a reform process to modernize and centralize specialized tertiary care and psychiatric care. Patients enjoy free choice of primary and specialized outpatient providers, though there are signs that accessibility is limited in some regions and for some specialties. Overall, health outcomes in terms of life expectancy, mortality and survival rates of stroke and cancer have improved in recent years, though these improvements have been slower in Czechia than in other countries. However, life expectancy dropped considerably due to heightened mortality resulting from the COVID-19 pandemic in 2020 and 2021. There remains considerable room for improvement in strengthening disease prevention and health promotion, particularly for dietary habits and health literacy. Various efforts to advance evidence-based interventions in the health system, such as the initiation of health care quality monitoring and health system performance assessment, will assist in further analysing Czechia's health outcomes.
Advance Healthcare Management Institute
Faculty of Social Sciences Charles University
Institute of Economic Studies Faculty of Social Sciences Charles University
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003894
- 003
- CZ-PrNML
- 005
- 20230425140932.0
- 007
- ta
- 008
- 230418s2023 dk f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)36951272
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Bryndová, Lucie $u Faculty of Social Sciences, Charles University
- 245 10
- $a Czechia: Health System Review / $c L. Bryndová, L. Šlegerová, J. Votápková, P. Hrobon, N. Shuftan, A. Spranger
- 520 9_
- $a This analysis of the Czech health system reviews developments in governance, organization, financing and delivery of care, health reforms and health system performance. Czechs have enjoyed a statutory health insurance system with a high level of financial protection, a broad benefits package and universal membership for over 30 years. The central level of the state, mostly represented through the Ministry of Health and its subordinated bodies, takes on the various roles of legislator, steward and even owner of various providers of care, while also making insurance contributions for the sizeable part of the population classified as economically inactive. Health insurance funds are responsible for contracting sufficient care provision for their members. The Czech health system has traditionally derived a majority of its financing from public sources, which stood at 81.5% of current health expenditure in 2019, as the latest available year of reference, with the rest coming from private sources. While health spending in Czechia is below the European Union (EU) average, the densities of acute care beds and primary care physicians are above respective EU averages. Ageing and a lack of qualified staff (for example, nurses in hospitals) are already putting pressure on the Czech health workforce, a bottleneck further exposed by the COVID-19 pandemic. Additionally, Czechia has embarked on a reform process to modernize and centralize specialized tertiary care and psychiatric care. Patients enjoy free choice of primary and specialized outpatient providers, though there are signs that accessibility is limited in some regions and for some specialties. Overall, health outcomes in terms of life expectancy, mortality and survival rates of stroke and cancer have improved in recent years, though these improvements have been slower in Czechia than in other countries. However, life expectancy dropped considerably due to heightened mortality resulting from the COVID-19 pandemic in 2020 and 2021. There remains considerable room for improvement in strengthening disease prevention and health promotion, particularly for dietary habits and health literacy. Various efforts to advance evidence-based interventions in the health system, such as the initiation of health care quality monitoring and health system performance assessment, will assist in further analysing Czechia's health outcomes.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a zdravotní politika $7 D006291
- 650 _2
- $a pandemie $7 D058873
- 650 12
- $a COVID-19 $x epidemiologie $7 D000086382
- 650 _2
- $a výdaje na zdravotnictví $7 D005102
- 650 _2
- $a kvalita zdravotní péče $7 D011787
- 650 _2
- $a zdravotní pojištění $7 D007348
- 650 _2
- $a reforma zdravotní péče $7 D018166
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šlegerová, Lenka $u Institute of Economic Studies, Faculty of Social Sciences, Charles University
- 700 1_
- $a Votápková, Jana $u Institute of Economic Studies, Faculty of Social Sciences, Charles University
- 700 1_
- $a Hrobon, Pavel $u Advance Healthcare Management Institute
- 700 1_
- $a Shuftan, Nathan $u European Observatory on Health Systems and Policies and Department of Health Care Management, Berlin University of Technology
- 700 1_
- $a Spranger, Anne $u European Observatory on Health Systems and Policies and Department of Health Care Management, Berlin University of Technology
- 773 0_
- $w MED00188758 $t Health systems in transition $x 1817-6127 $g Roč. 25, č. 1 (2023), s. 1-216
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36951272 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140929 $b ABA008
- 999 __
- $a ok $b bmc $g 1924507 $s 1190103
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 25 $c 1 $d 1-216 $e - $i 1817-6127 $m Health systems in transition $n Health Syst Transit $x MED00188758
- LZP __
- $a Pubmed-20230418